Showing 1,021 - 1,040 results of 110,788 for search '(( 20 c decrease ) OR ( 5 ((((wt decrease) OR (a decrease))) OR (we decrease)) ))', query time: 1.88s Refine Results
  1. 1021
  2. 1022
  3. 1023

    GluN2A(D731N) enhances sensitivity to endogenous proton and zinc ions. by Kai Gao (120150)

    Published 2017
    “…(<b>C</b>) The composite zinc concentration-response curves show an enhanced sensitivity of the GluN2A(D731N)-containing receptors to zinc compared to the WT NMDA receptors. …”
  4. 1024
  5. 1025

    Decreased cardiomyocyte proliferation in <i>Nkx2.5-Cre/Foxm1<sup>fl/fl</sup></i> hearts. by Craig Bolte (299486)

    Published 2013
    “…<p>Microtome sections of paraffin-embedded hearts were prepared from <i>Nkx2.5-Cre/Foxm1<sup>fl/fl</sup></i> and control mice at E14.5 (A–D, J–K), E17.5 (E–F) and P11 (G–H) and stained for proliferation markers phospho-histone 3 (PH3) (A–B, E–H, J–K) and Ki-67 (C–D). …”
  6. 1026
  7. 1027
  8. 1028
  9. 1029

    DataSheet1_Decreased ATF5 level contributes to improved mitochondrial function in oocytes exposed to vitrification stress.docx by Guizhen Zhou (12174713)

    Published 2024
    “…Reduced ATF5 expression to a homeostatic level in vitrified oocytes led to accumulated unfolded protein levels and increased mitochondrial membrane potential. …”
  10. 1030

    Image 5_G. vaginalis increases HSV-2 infection by decreasing vaginal barrier integrity and increasing inflammation in vivo.tif by Nuzhat Rahman (16660416)

    Published 2024
    “…</p>Methods<p>Mice were inoculated with 10<sup>7</sup> CFU of the eubiotic bacteria Lactobacillus crispatus, the dysbiotic bacteria G. vaginalis, or PBS as a negative control every 48 h for ten days. On day ten, mice were inoculated with 10<sup>5</sup> PFU WT HSV-2 333 and survival, pathology, and viral titers were assessed. …”
  11. 1031
  12. 1032
  13. 1033
  14. 1034
  15. 1035

    Image5_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
  16. 1036
  17. 1037
  18. 1038
  19. 1039
  20. 1040